BIOCRYST PHARMACEUTICALS INC (BCRX) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 2, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 2, 2026 filed Aug. 31, 2026 | Stonehouse Jon P Director | $6,247 | 644 | +0% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | Milne Jill C. Director | $12,494 | 1,288 | +4% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | MILANO VINCENT Director | $11,242 | 1,159 | +1% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | McKee Amy E Director | $6,247 | 644 | +1% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | Frank Steven Director | $12,494 | 1,288 | +4% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free